drugset / Trial / NCT00359177
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate how subjects with mild or moderate liver problems process or breakdown the study drug GW679769 in their bodies as compared to healthy subjects.
Timeline
- Start
- 2005-12-01
- Primary completion
- 2006-10-12
- Completion
- 2006-10-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casopitant | Small molecule | 100 mg | Oral |
Indications
No indication recorded.